Videos

A panel of experts provide an overview of choosing endometriosis treatment and how to discuss these options with patients.

A panel of experts provide an overview of GnRH antagonists trial data for the treatment of endometriosis.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the role of surgery and GnRh agonists for the treatment of endometriosis.

Hugh Taylor, MD, along with a panel of experts, discuss the role of GnRH antagonists for the treatment of patients with endometriosis.

Endometriosis experts describe the considerations of selecting a therapy for patients who are suffering from endometriosis.

A panel of experts provide an overview of first-line treatments for endometriosis treatment.

An expert in obstetrics and gynecology comments on the utilization of GnRH agonists and GnRH antagonists in COS in IVF treatment.

Steven J. Ory, MD, discusses controlled ovarian stimulation (COS) and the use of a gonadotropin-releasing hormone (GnRH) agonist or antagonist as an important step in the IVF process.

Steven J. Ory, MD, reviews the prevalence of infertility among women in the US and provides an overview of the types of testing done to evaluate infertility.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the multidisciplinary approach and shared decision-making strategies associated with endometriosis treatment.

Hugh Taylor, MD, along with a panel of experts, discuss the different challenges of diagnosing endometriosis as well as explaining why there is commonly a delay in diagnosis.

Endometriosis experts describe the potential physical, social, and psychological impact the disease may have on patients lives.

A panel of experts provide an overview of the health complications that are associated with endometriosis.

In this interview, Michael Krychman, MD, a community-based gynecologist in Newport Beach, California, takes a look at 2022 advances within the contraceptive space, as well as looks toward the future.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the 3 main types of endometriosis and the commonly associated symptoms and risk factors.

Hugh Taylor, MD, leads a discussion with a panel of experts about the prevalence of endometriosis.

Jeff Andrews, MD, ob-gyn and vice president of Medical Affairs at BD, sits with Contemporary OB/GYN® to discuss the findings from a survey by the Harris Poll regarding HPV and cervical cancer screening.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, comment on unmet needs and challenges faced by patients looking for contraception.

Experts in gynecology share practical resources for patients and providers on the currently available contraceptive options.

Drs Jenna Beckham and Thomas Kimble review the benefits of newly approved contraceptive systems, such as use in women with higher BMIs and ease of access.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, discuss patient misconceptions around contraceptive options and the impact on adherence.

Drs Jenna Beckham and Thomas Kimble comment on hormonal patch and vaginal gel contraceptives.

Experts in gynecology review other contraception methods, including the contraceptive ring and drospirenone and estetrol tablets.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, provide an overview of newly approved contraceptive modalities.

Thomas Kimble, MD, reviews potential cardiovascular risks associated with some contraceptives.

Drs Jenna Beckham and Thomas Kimble discuss the safety and efficacy of contraceptives for patients with a higher body mass Index (BMI).

Thomas Kimble, MD, provides an overview of currently available hormonal contraceptive options.

Hear from David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of the American College of Obstetricians and Gynecologists' Ohio chapter, as he recaps the restrictions on reproductive rights from a ground-floor perspective.

Marco Taglietti, MD, president and CEO of Scynexis, sits with Contemporary OB/GYN® to discuss the recent approval of ibrexafungerp (Brexafemme) for the reduction in incidence of recurrent vulvovaginal candidiasis.

Experts in gynecology consider the role of pharmacists and other healthcare providers in contraceptive counseling and education.